Tuesday, June 26th, 2007 - Alimta®/Platinum-compound Combination Confirmed Active in Mesothelioma
Archive for the 'Carboplatin (Paraplatin®)' Category
Tuesday, June 20th, 2006 - CuraGen and TopoTarget Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for Mesothelioma
Sunday, June 4th, 2006 - Updated Analysis in Second-Line Treatment of Lung Cancer Trial Confirms Similar Survival for Alimta(R) and Docetaxel; Alimta Also Shows Tolerability as Triplet Combination Treatment in First-Line Lung Cancer
Tuesday, May 23rd, 2006 - Lilly Oncology Prepares for Strong Showing at ASCO 2006; Targets Breast Cancer and Other Tumors with 79 Studies: 11 breast cancer studies; 29 thoracic cancer studies; and 8 studies with developing targeted agent
Thursday, February 24th, 2005 - Key ONCONASE ® Findings Presented at AACR Special Lung Cancer Conference: Findings discussed include ONCONASE’s enhancement of the efficacy of commonly used chemotherapeutic agents such as cisplatin and carboplatin
Thursday, August 19th, 2004 - FDA Approves Lilly’s Alimta(R) (pemetrexed) for the Second-Line Treatment of Advanced Lung Cancer: Accelerated Approval Results in Second U.S. Indication in Six Months for Alimta
Tuesday, October 22nd, 2002 - Alimta Continues To Show Versatility in Treating Different Cancers
Tuesday, August 20th, 2002 - New Drug Nearly Doubles Survival Time For Mesothelioma Patients Pain, Other Symptoms Also Eased For Many
